Nevertheless, these findings suggest that inflammation, rather than neuroprotective or antioxidant factors (at least EPO and PRDX1), is a possible determinant of the occurrence of secondary ischemic events in patients with TIA or lacunar stroke. This evidence concerns the gene PRDX1 and transient ischemic attack.